Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer... ( BTA stat(R) Test Detects Bladder Tumo...)

Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection

Date:1/29/2009

BTA stat(R) Test Detects Bladder Tumor Associated Antigen in Urine

CORTLANDT MANOR, N.Y., Jan. 29 /PRNewswire/ -- Polymedco, Inc. is pleased to announce the direct availability of the BTA stat(R) test from our sales force -- The BTA stat(R) test is a point of care technology for the early detection of recurrent bladder cancer. This method uses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urine. It is a single-step, rapid immunochromatographic assay for bladder tumor-associated antigen in voided urine. The specificity of the BTA stat(R) test was 93 - 95% in patients with non-genitourinary diseases and cancers and healthy individuals tested as part of a multi-center study. The test has a sensitivity that is considerably higher than voided urine cytology, enabling detection of recurrent early stage and grade cancers that cytology often misses. Requiring three drops of urine, the result is delivered in only five minutes. The appearance of a line in the patient window indicates a positive result. The BTA stat(R) test requires one voided urine sample with no sample preparation. The BTA stat(R) test is CLIA waived and also available for prescription home use.

Bladder cancer is the fourth most common cancer among men. Over 14,000 deaths are expected this year and 68,810 new cases will be diagnosed with the disease. It has a 5-year survival rate of 94% if caught early and recurs in over 88% of patients within fifteen years, calling for regular testing and lifelong management.

Polymedco, Inc. is one of the leading marketing and distribution companies in the clinical laboratory marketplace. Since the company's inception in 1980, Polymedco has evolved into a highly skilled and successful sales, marketing and manufacturing organization.

For More Information, please contact Polymedco at 800-431-2123 or 914-739-5400, or
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. PATHFAST(R): Rapid Whole Blood Immunoassay Analyzer from Polymedco
2. Delta Dental of Illinois Introduces Smile Smart For Your Health
3. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
5. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
6. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
7. Triveris Introduces Personal Health Record with Built-in Health Advisor
8. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
9. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
10. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
11. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)

Post Your Comments:

Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer...( BTA stat(R) Test Detects Bladder Tumo...),Health